Along with several new cancer drugs Farxiga has helped revive AZ’s fortunes and returned the company to growth. According to figures from IQVIA cited by Glenmark, sales for the 12 month period ...

Farxiga is one of AZ’s most important drugs, and sales increased by 14% to $726 million in the first half of the year, although this was slower than the growth seen in 2018 when sales grew at 30 ...

Farxiga (dapagliflozin) and Jardiance (empagliflozin) are prescription medications that are commonly used for type 2 diabetes ...